Honored to Win the 2022 Healthcare & Pharmaceutical Awards


Dotmatics Named “Best Scientific R&D Software Developer & Cloud Vendor”

Recently, the health and wellbeing of millions around the world has been under increased threat due to the pandemic. In many ways, the COVID-19 crisis highlighted critical industry challenges that have been growing for decades, in particular the need for rapid acceleration of scientific research and collaboration to produce faster, more successful breakthroughs.

Now in its eighth year, in 2022 the Global Health & Pharma’s Healthcare & Pharmaceutical Award recognized and awarded companies and individuals who served a variety of purposes during the pandemic—from researching and developing innovative pharmaceutical products to combat the virus, to providing exceptional healthcare services to patients. And this year, Dotmatics was named the “Best Scientific R&D Software Developer & Cloud Vendor.” 

“The pandemic put a big spotlight on a pain that already existed, and pushed digital transformation to the forefront of many companies’ strategic initiatives,” said Steve Tharp, SVP Customer Ops at Dotmatics. “Whether focused on COVID-19, cancer research or food scarcity, we know that scientists struggle with their data stuck in silos. We’re working to build the first true end-to-end solution for scientific R&D to better support scientists committed to all manner of life-saving discoveries.”

The Dotmatics team is developing an integrated R&D platform with the depth, breadth, and connectivity to the best scientific applications to help solve the complex data challenges scientists face in lab environments. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Our global team of more than 800 people is dedicated to supporting our customers in over 180 countries.

Learn More

Request a demo to learn more about the Dotmatics platform and how it can help researchers make informed, data-driven decisions.

Get the latest science news in your inbox.